Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of low dose IL-2 and an inhibitor of Treg IL-2R desensitization to treat autoimmune and allergic inflammatory diseases

Combination of low dose IL-2 and an inhibitor of Treg IL-2R desensitization to treat autoimmune and allergic inflammatory diseases

US Patent 11701406 · Granted Jul 18, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds, compositions, methods, and uses for treating insulin resistance, type2025
Methods and compounds for treating disorders2023
Compositions and methods for treating diseases2015
Compositions and methods for treating diseases2014
Transient expression of immunomodulatory polypeptides for the prevention and tre2013
Polypeptide complex that regulates cell cycle and anergy2011
Polypeptide complex that regulates cell cycle and anergy2011
Compositions and methods for treating diseases2010
Compositions and methods for treating diseases2009
Gene therapy for the prevention of autoimmune disease2008
Anergy associated genes2004
Anergy genes1998